Abstract
Background and Aim
Association between obesity and endoscopic resection outcomes has not been investigated. We sought to determine the clinical impact of obesity in patients who underwent endoscopic submucosal dissection (ESD) for gastric neoplasia.
Methods
A total of 1571 consecutive patients with gastric neoplasia who underwent ESD between December 2010 and March 2016 were enrolled in this study. We retrospectively analyzed 1181 cases that were divided into three groups based upon body mass index (BMI, kg/m2) according to the criteria for Asia-Pacific populations: normal (<23, n = 411), overweight (≥23 and <25, n = 312), and obese (≥25, n = 458). Demographics, endoscopic findings, pathologic results, and clinical outcomes were analyzed.
Results
No significant differences were observed between the three BMI groups in the following measures: the en-bloc resection rate, the complete resection rate, lymphovascular involvement or submucosal invasion of tumor cells, and adverse events. However, when comparing the obese and overweight groups with the normal group, mean procedure time was longer (P = 0.001) and the percentage of cases requiring more than 30 min, which was the overall mean procedure time, was greater (60.7, 53.2, and 50.1%, respectively; P = 0.006). The significantly associated factors with procedure durations longer than 30 min were obesity, longitudinal and circumferential location, large resection size (≥4 cm), cancer pathology, and submucosal layer invasion. In multivariate analyses, obesity was an independent predictor of long procedure time for gastric ESD.
Conclusion
Being obese or overweight did not directly affect clinical outcomes in gastric ESD. However, obesity was significantly associated with long procedure time. Our results suggest that gastric ESD can be performed safely and effectively in obese patients.
Similar content being viewed by others
References
Bickenbach KA, Denton B, Gonen M, Brennan MF, Coit DG, Strong VE. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol. 2013;20:780–787. doi:10.1245/s10434-012-2653-3.
Kulig J, Sierzega M, Kolodziejczyk P, et al. Implications of overweight in gastric cancer: a multicenter study in a Western patient population. Eur J Surg Oncol. 2010;36:969–976. doi:10.1016/j.ejso.2010.07.007.
Tao W, Lagergren J. Clinical management of obese patients with cancer. Nat Rev Clin Oncol. 2013;10:519–533. doi:10.1038/nrclinonc.2013.120.
Yasunaga H, Horiguchi H, Matsuda S, Fushimi K, Hashimoto H, Ayanian JZ. Body mass index and outcomes following gastrointestinal cancer surgery in Japan. Br J Surg. 2013;100:1335–1343. doi:10.1002/bjs.9221.
Kim KH, Kim MC, Jung GJ, Kim HH. The impact of obesity on LADG for early gastric cancer. Gastric Cancer. 2006;9:303–307. doi:10.1007/s10120-006-0395-2.
Miyaki A, Imamura K, Kobayashi R, Takami M, Matsumoto J. Impact of visceral fat on laparoscopy-assisted distal gastrectomy. Surgeon. 2013;11:76–81. doi:10.1016/j.surge.2012.07.001.
Chen HN, Chen XZ, Zhang WH, et al. The impact of body mass index on the surgical outcomes of patients with gastric cancer: a 10-year, single-institution cohort study. Medicine. 2015;94:e1769. doi:10.1097/md.0000000000001769.
Noshiro H, Shimizu S, Nagai E, Ohuchida K, Tanaka M. Laparoscopy-assisted distal gastrectomy for early gastric cancer: is it beneficial for patients of heavier weight? Ann Surg. 2003;238:680–685. doi:10.1097/01.sla.0000094302.51616.2a.
Lee HJ, Kim HH, Kim MC, et al. The impact of a high body mass index on laparoscopy assisted gastrectomy for gastric cancer. Surg Endosc. 2009;23:2473–2479. doi:10.1007/s00464-009-0419-1.
Wang Z, Zhang X, Liang J, Hu J, Zeng W, Zhou Z. Short-term outcomes for laparoscopy-assisted distal gastrectomy for body mass index ≥30 patients with gastric cancer. J Surg Res. 2015;195:83–88. doi:10.1016/j.jss.2014.12.044.
Yamada H, Kojima K, Inokuchi M, Kawano T, Sugihara K. Effect of obesity on technical feasibility and postoperative outcomes of laparoscopy-assisted distal gastrectomy—comparison with open distal gastrectomy. J Gastrointest Surg. 2008;12:997–1004. doi:10.1007/s11605-007-0374-x.
Harold KL, Pollinger H, Matthews B, Kercher K, Sing R, Heniford B. Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries. Surg Endosc Interv Tech. 2003;17:1228–1230.
Sutton C. Power sources in endoscopic surgery. Curr Opin Obstet Gynecol. 1995;7:248–256.
Okada K, Yamamoto Y, Kasuga A, et al. Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc. 2011;25:98–107. doi:10.1007/s00464-010-1137-4.
Mannen K, Tsunada S, Hara M, et al. Risk factors for complications of endoscopic submucosal dissection in gastric tumors: analysis of 478 lesions. J Gastroenterol. 2010;45:30–36. doi:10.1007/s00535-009-0137-4.
WHO. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia; 2000.
Schlemper R, Riddell R, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–255.
Gotoda T, Iwasaki M, Kusano C, Seewald S, Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–871. doi:10.1002/bjs.7033.
Ojima T, Takifuji K, Nakamura M, et al. Complications of endoscopic submucosal dissection for gastric noninvasive neoplasia: an analysis of 647 lesions. Surg Laparosc Endosc Percutan Tech. 2014;24:370–374. doi:10.1097/SLE.0b013e318290132e.
Ohno T, Mochiki E, Ando H, et al. The benefits of laparoscopically assisted distal gastrectomy for obese patients. Surg Endosc. 2010;24:2770–2775. doi:10.1007/s00464-010-1044-8.
Wu XS, Wu WG, Li ML, et al. Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol. 2013;19:4596–4606. doi:10.3748/wjg.v19.i28.4596.
Ahn JY, Choi KD, Choi JY, et al. Procedure time of endoscopic submucosal dissection according to the size and location of early gastric cancers: analysis of 916 dissections performed by 4 experts. Gastrointest Endosc. 2011;73:911–916. doi:10.1016/j.gie.2010.11.046.
Emura F, Mejia J, Donneys A, et al. Therapeutic outcomes of endoscopic submucosal dissection of differentiated early gastric cancer in a Western endoscopy setting (with video). Gastrointest Endosc. 2015;82:804–811. doi:10.1016/j.gie.2015.03.1960.
Lu ZS, Yang YS, Feng D, et al. Predictive factors of endoscopic submucosal dissection procedure time for gastric superficial neoplasia. World J Gastroenterol. 2012;18:7009–7014. doi:10.3748/wjg.v18.i47.7009.
Toyokawa T, Inaba T, Omote S, et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol. 2012;27:907–912. doi:10.1111/j.1440-1746.2011.07039.x.
Lim SM, Park JC, Lee H, Shin SK, Lee SK, Lee YC. Impact of cumulative time on the clinical outcomes of endoscopic submucosal dissection in gastric neoplasm. Surg Endosc. 2013;27:1397–1403. doi:10.1007/s00464-012-2643-3.
Funding
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology (NRF-2013R1A1A2007985) and by a grant from the Global Research and Development Center through the National Research Foundation of Korea, which was funded by the Ministry of Science, ICT, and Future Planning (NRF-2011-0031644).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Kang, D., Ha, S.E., Park, J.M. et al. Body Mass Index and Clinical Outcomes from Endoscopic Submucosal Dissection of Gastric Neoplasia. Dig Dis Sci 62, 1657–1665 (2017). https://doi.org/10.1007/s10620-017-4560-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-017-4560-8